AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 0.9 |
Market Cap | 84.20M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.06 |
PE Ratio (ttm) | -18.02 |
Forward PE | n/a |
Analyst | n/a |
Ask | 1.09 |
Volume | 85,268 |
Avg. Volume (20D) | 201,560 |
Open | 1.10 |
Previous Close | 1.08 |
Day's Range | 1.08 - 1.13 |
52-Week Range | 0.54 - 1.27 |
Beta | undefined |
About MLSS
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a ...
Next Earnings Release
Analysts project revenue of $2.81M, reflecting a 24.28% YoY growth and earnings per share of -0.01, making a -66.67% decrease YoY.
2 months ago · seekingalpha.com
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call TranscriptMilestone Scientific Inc. (NYSE:MLSS ) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants David Waldman - Crescendo Communications, Investor Relations Arjan Haverhals -...